A new report from Simba surveys the current scientific and technical publishing markets. These segments are essentially flat. Incumbents are seeking growth elsewhere. Interestingly, open access has not had much of an impact on the revenue of traditional publications.
Articles are published before they’re reviewed; doubts about a paper are viewed as a positive status; papers only need to contain “science;” review and revision can continue forever; and PubMed Central is their certifying entity. Welcome to the world of F1000 Research.
Making sense of non-events (citation, circulation, and publication) requires context and a tolerance for uncertainty.
Can tweets predict future citations? A study of article tweets raises validity and ethical concerns.
2Collab and Connotea are choking on spam, and they may not have the right scale or architecture to avoid a future defined by it.
Elsevier’s “Article of the Future” prototypes appear, and only spotlight the underlying conceptual problems for a traditional, article-centric publisher.